(Q45993671)

18 December 2017

title

Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice. (English)

1 reference

18 December 2017

author name string

Young-Cheol Lim

1

1 reference

18 December 2017

Mahendra Prasad Bhatt

2

1 reference

18 December 2017

Mi-Hye Kwon

3

1 reference

18 December 2017

Donghyun Park

4

1 reference

18 December 2017

Seungkoo Lee

5

1 reference

18 December 2017

Jongseon Choe

6

1 reference

18 December 2017

Jongyun Hwang

7

1 reference

18 December 2017

Young-Myeong Kim

8

1 reference

18 December 2017

Kwon-Soo Ha

9

1 reference

18 December 2017

publication date

18 October 2013

1 reference

18 December 2017

published in

Cardiovascular Research

1 reference

18 December 2017

volume

101

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

155-164

1 reference

18 December 2017

The clinical potential of C-peptide replacement in type 1 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide is a bioactive peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide as a therapeutic tool in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Cellular and physiological effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Molecular effects of C-Peptide in microvascular blood flow regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

21 January 2018

Retinopathy in diabetes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Vascular endothelial growth factor and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Role of NADPH oxidase in retinal vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Role of GTPases in control of microvascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

A novel array-based assay of in situ tissue transglutaminase activity in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Differential cytotoxic responses to low- and high-dose photodynamic therapy in human gastric and bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

A new view of diabetic retinopathy: a neurodegenerative disease of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Endothelial pathomechanisms in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Ca2+ signaling, TRP channels, and endothelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVT238

21 January 2018

Identifiers

DOI

10.1093/CVR/CVT238

1 reference

18 December 2017

1 reference

18 December 2017